Investor Overview

Corporate Profile
ContraFect Corporation is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. Due to drug-resistant and newly emerging pathogens, hospital acquired infections are currently the fourth leading cause of death in the United States, following heart disease, cancer and stroke. We intend to address drug-resistant infections using our therapeutic product candidates from our lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation).
Stock Quote
ExchangeNASDAQ CM (US Dollar)
Price$2.25
Change (%)0.00 (0.00%)
Volume0
Data as of 02/22/17 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Press ReleasesMore >>
DateTitle  
02/15/17Lisa Ricciardi to Join Board of Directors
YONKERS, NY -- (Marketwired) -- 02/15/17 -- ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, announced today that it has appointed Lisa Ricciardi to its Board of Directors. Ms. Ricciardi is a Life Sciences executive with deep business development and operational experience. She has worked for top pharmaceutical, payer, and molecul... 
 Printer Friendly Version
01/06/17ContraFect Provides Program Update
YONKERS, NY -- (Marketwired) -- 01/06/17 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today provided an update on its clinical development timeline for CF-301. The company now expects to initiate the Phase 2 study of CF-301 in patients with Staphylococcus aureus (Staph aureus) ... 
 Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ContraFect Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share

X
| E-mail Alerts E-mail Alerts | IR Contacts Contact IR | Financial Tear Sheet Tear Sheet